SLCO2A1 and ischemia: Here we hypothesize that SLCO2A1 loss-of-function mutations might cause vascular function alterations or ischemia, leading to vasodilation and fibrotic proliferation in intestinal lesions, which hopefully may provide clues to the future pathogenic mechanism of CEAS.